Implementation of the 2018 ESC/ESH Guidelines for the management of hypertension in primary care: the HYPEDIA study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-07-14

AUTHORS

Anastasios Kollias, Emmanouil Foukarakis, Konstantinos Karakousis, George S. Stergiou

ABSTRACT

The HYPEDIA study aimed at evaluating the implementation of the 2018 European guidelines for treating hypertension in primary care. A nationwide prospective non-interventional cross-sectional study was performed in consecutive untreated or treated hypertensives recruited mainly in primary care in Greece. Participants’ characteristics, office blood pressure (BP) (triplicate automated measurements, Microlife BPA3 PC) and treatment changes were recorded on a cloud platform. A total of 3,122 patients (mean age 64 ± 12.5 [SD] years, 52% males) were assessed by 181 doctors and 3 hospital centers. In 772 untreated hypertensives (25%), drug treatment was initiated in the majority, with monotherapy in 53.4%, two-drug combination in 36.3%, and three drugs in 10.3%. Angiotensin receptor blocker (ARB) monotherapy was initiated in 30%, ARB/calcium channel blocker (CCB) 20%, ARB/thiazide 8%, angiotensin converting enzyme inhibitor (ACEi)-based 19%. Of the combinations used, 97% were in single-pill. Among 977 treated hypertensives aged <65 years, 79% had BP ≥ 130/80 mmHg (systolic and/or diastolic), whereas among 1,373 aged ≥65 years, 66% had BP ≥ 140/80 mmHg. ARBs were used in 69% of treated hypertensives, CCBs 47%, ACEis 19%, diuretics 39%, beta-blockers 19%. Treatment modification was decided in 53% of treated hypertensives aged <65 years with BP ≥ 130/80 mmHg and in 62% of those ≥65 years with BP ≥ 140/80 mmHg. Renin-angiotensin system blocker-based therapy constitutes the basis of antihypertensive drug treatment in most patients in primary care, with wide use of single-pill combinations. In almost half of treated uncontrolled hypertensives, treatment was not intensified, suggesting suboptimal implementation of the guidelines and possible physician inertia. More... »

PAGES

1-6

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41371-022-00713-w

DOI

http://dx.doi.org/10.1038/s41371-022-00713-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149469036

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35835860


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.5216.0", 
          "name": [
            "Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kollias", 
        "givenName": "Anastasios", 
        "id": "sg:person.01271226125.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271226125.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Venizeleio General Hospital, Heraklion, Crete, Greece", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Cardiology, Venizeleio General Hospital, Heraklion, Crete, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Foukarakis", 
        "givenName": "Emmanouil", 
        "id": "sg:person.01102146313.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102146313.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Larissa General Hospital, Larissa, Greece", 
          "id": "http://www.grid.ac/institutes/grid.411299.6", 
          "name": [
            "Department of Internal Medicine, Larissa General Hospital, Larissa, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karakousis", 
        "givenName": "Konstantinos", 
        "id": "sg:person.011623045707.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011623045707.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.5216.0", 
          "name": [
            "Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stergiou", 
        "givenName": "George S.", 
        "id": "sg:person.01251075343.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251075343.50"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2022-07-14", 
    "datePublishedReg": "2022-07-14", 
    "description": "The HYPEDIA study aimed at evaluating the implementation of the 2018 European guidelines for treating hypertension in primary care. A nationwide prospective non-interventional cross-sectional study was performed in consecutive untreated or treated hypertensives recruited mainly in primary care in Greece. Participants\u2019 characteristics, office blood pressure (BP) (triplicate automated measurements, Microlife BPA3 PC) and treatment changes were recorded on a cloud platform. A total of 3,122 patients (mean age 64\u2009\u00b1\u200912.5 [SD] years, 52% males) were assessed by 181 doctors and 3 hospital centers. In 772 untreated hypertensives (25%), drug treatment was initiated in the majority, with monotherapy in 53.4%, two-drug combination in 36.3%, and three drugs in 10.3%. Angiotensin receptor blocker (ARB) monotherapy was initiated in 30%, ARB/calcium channel blocker (CCB) 20%, ARB/thiazide 8%, angiotensin converting enzyme inhibitor (ACEi)-based 19%. Of the combinations used, 97% were in single-pill. Among 977 treated hypertensives aged <65 years, 79% had BP\u2009\u2265\u2009130/80\u2009mmHg (systolic and/or diastolic), whereas among 1,373 aged \u226565 years, 66% had BP\u2009\u2265\u2009140/80\u2009mmHg. ARBs were used in 69% of treated hypertensives, CCBs 47%, ACEis 19%, diuretics 39%, beta-blockers 19%. Treatment modification was decided in 53% of treated hypertensives aged <65 years with BP\u2009\u2265\u2009130/80\u2009mmHg and in 62% of those \u226565 years with BP\u2009\u2265\u2009140/80\u2009mmHg. Renin-angiotensin system blocker-based therapy constitutes the basis of antihypertensive drug treatment in most patients in primary care, with wide use of single-pill combinations. In almost half of treated uncontrolled hypertensives, treatment was not intensified, suggesting suboptimal implementation of the guidelines and possible physician inertia.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41371-022-00713-w", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1098658", 
        "issn": [
          "0950-9240", 
          "1476-5527"
        ], 
        "name": "Journal of Human Hypertension", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "blood pressure", 
      "primary care", 
      "drug treatment", 
      "non-interventional cross-sectional study", 
      "angiotensin receptor blocker monotherapy", 
      "ESC/ESH guidelines", 
      "office blood pressure", 
      "antihypertensive drug treatment", 
      "single-pill combination", 
      "management of hypertension", 
      "two-drug combinations", 
      "cross-sectional study", 
      "physician inertia", 
      "uncontrolled hypertensives", 
      "most patients", 
      "ESH guidelines", 
      "untreated hypertensives", 
      "treatment modification", 
      "Hospital Center", 
      "hypertensives", 
      "treatment changes", 
      "enzyme inhibitors", 
      "European guidelines", 
      "mmHg", 
      "participant characteristics", 
      "care", 
      "hypertension", 
      "monotherapy", 
      "patients", 
      "treatment", 
      "suboptimal implementation", 
      "guidelines", 
      "years", 
      "angiotensin", 
      "ARBs", 
      "therapy", 
      "study", 
      "drugs", 
      "total", 
      "doctors", 
      "inhibitors", 
      "combination", 
      "wide use", 
      "majority", 
      "management", 
      "half", 
      "center", 
      "changes", 
      "pressure", 
      "characteristics", 
      "use", 
      "modification", 
      "implementation", 
      "basis", 
      "Greece", 
      "platform", 
      "inertia", 
      "cloud platform"
    ], 
    "name": "Implementation of the 2018 ESC/ESH Guidelines for the management of hypertension in primary care: the HYPEDIA study", 
    "pagination": "1-6", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149469036"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41371-022-00713-w"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35835860"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41371-022-00713-w", 
      "https://app.dimensions.ai/details/publication/pub.1149469036"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_932.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41371-022-00713-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00713-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00713-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00713-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41371-022-00713-w'


 

This table displays all metadata directly associated to this object as RDF triples.

140 TRIPLES      20 PREDICATES      81 URIs      73 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41371-022-00713-w schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N8a8ab3f84ce74b72af8dd5f9c8162659
4 schema:datePublished 2022-07-14
5 schema:datePublishedReg 2022-07-14
6 schema:description The HYPEDIA study aimed at evaluating the implementation of the 2018 European guidelines for treating hypertension in primary care. A nationwide prospective non-interventional cross-sectional study was performed in consecutive untreated or treated hypertensives recruited mainly in primary care in Greece. Participants’ characteristics, office blood pressure (BP) (triplicate automated measurements, Microlife BPA3 PC) and treatment changes were recorded on a cloud platform. A total of 3,122 patients (mean age 64 ± 12.5 [SD] years, 52% males) were assessed by 181 doctors and 3 hospital centers. In 772 untreated hypertensives (25%), drug treatment was initiated in the majority, with monotherapy in 53.4%, two-drug combination in 36.3%, and three drugs in 10.3%. Angiotensin receptor blocker (ARB) monotherapy was initiated in 30%, ARB/calcium channel blocker (CCB) 20%, ARB/thiazide 8%, angiotensin converting enzyme inhibitor (ACEi)-based 19%. Of the combinations used, 97% were in single-pill. Among 977 treated hypertensives aged <65 years, 79% had BP ≥ 130/80 mmHg (systolic and/or diastolic), whereas among 1,373 aged ≥65 years, 66% had BP ≥ 140/80 mmHg. ARBs were used in 69% of treated hypertensives, CCBs 47%, ACEis 19%, diuretics 39%, beta-blockers 19%. Treatment modification was decided in 53% of treated hypertensives aged <65 years with BP ≥ 130/80 mmHg and in 62% of those ≥65 years with BP ≥ 140/80 mmHg. Renin-angiotensin system blocker-based therapy constitutes the basis of antihypertensive drug treatment in most patients in primary care, with wide use of single-pill combinations. In almost half of treated uncontrolled hypertensives, treatment was not intensified, suggesting suboptimal implementation of the guidelines and possible physician inertia.
7 schema:genre article
8 schema:isAccessibleForFree true
9 schema:isPartOf sg:journal.1098658
10 schema:keywords ARBs
11 ESC/ESH guidelines
12 ESH guidelines
13 European guidelines
14 Greece
15 Hospital Center
16 angiotensin
17 angiotensin receptor blocker monotherapy
18 antihypertensive drug treatment
19 basis
20 blood pressure
21 care
22 center
23 changes
24 characteristics
25 cloud platform
26 combination
27 cross-sectional study
28 doctors
29 drug treatment
30 drugs
31 enzyme inhibitors
32 guidelines
33 half
34 hypertension
35 hypertensives
36 implementation
37 inertia
38 inhibitors
39 majority
40 management
41 management of hypertension
42 mmHg
43 modification
44 monotherapy
45 most patients
46 non-interventional cross-sectional study
47 office blood pressure
48 participant characteristics
49 patients
50 physician inertia
51 platform
52 pressure
53 primary care
54 single-pill combination
55 study
56 suboptimal implementation
57 therapy
58 total
59 treatment
60 treatment changes
61 treatment modification
62 two-drug combinations
63 uncontrolled hypertensives
64 untreated hypertensives
65 use
66 wide use
67 years
68 schema:name Implementation of the 2018 ESC/ESH Guidelines for the management of hypertension in primary care: the HYPEDIA study
69 schema:pagination 1-6
70 schema:productId N3831f8f6274947aab868dfe70a801b52
71 N99518b78919c439db09dd02cb455f85c
72 Na57d6c0fd1cc40c69ff5f73d1d877170
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149469036
74 https://doi.org/10.1038/s41371-022-00713-w
75 schema:sdDatePublished 2022-10-01T06:50
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher Na1e2cc2135f749abac8b15235069e6e7
78 schema:url https://doi.org/10.1038/s41371-022-00713-w
79 sgo:license sg:explorer/license/
80 sgo:sdDataset articles
81 rdf:type schema:ScholarlyArticle
82 N0002b5b690bf428a921524f53bfef820 rdf:first sg:person.01251075343.50
83 rdf:rest rdf:nil
84 N179eb9d7c47f4505ae746fadad044087 rdf:first sg:person.01102146313.08
85 rdf:rest Ndce63f5f13a84118908e88eb97d223a3
86 N3831f8f6274947aab868dfe70a801b52 schema:name doi
87 schema:value 10.1038/s41371-022-00713-w
88 rdf:type schema:PropertyValue
89 N8a8ab3f84ce74b72af8dd5f9c8162659 rdf:first sg:person.01271226125.41
90 rdf:rest N179eb9d7c47f4505ae746fadad044087
91 N99518b78919c439db09dd02cb455f85c schema:name pubmed_id
92 schema:value 35835860
93 rdf:type schema:PropertyValue
94 Na1e2cc2135f749abac8b15235069e6e7 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 Na57d6c0fd1cc40c69ff5f73d1d877170 schema:name dimensions_id
97 schema:value pub.1149469036
98 rdf:type schema:PropertyValue
99 Ndce63f5f13a84118908e88eb97d223a3 rdf:first sg:person.011623045707.49
100 rdf:rest N0002b5b690bf428a921524f53bfef820
101 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
102 schema:name Medical and Health Sciences
103 rdf:type schema:DefinedTerm
104 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
105 schema:name Cardiorespiratory Medicine and Haematology
106 rdf:type schema:DefinedTerm
107 sg:journal.1098658 schema:issn 0950-9240
108 1476-5527
109 schema:name Journal of Human Hypertension
110 schema:publisher Springer Nature
111 rdf:type schema:Periodical
112 sg:person.01102146313.08 schema:affiliation grid-institutes:None
113 schema:familyName Foukarakis
114 schema:givenName Emmanouil
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102146313.08
116 rdf:type schema:Person
117 sg:person.011623045707.49 schema:affiliation grid-institutes:grid.411299.6
118 schema:familyName Karakousis
119 schema:givenName Konstantinos
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011623045707.49
121 rdf:type schema:Person
122 sg:person.01251075343.50 schema:affiliation grid-institutes:grid.5216.0
123 schema:familyName Stergiou
124 schema:givenName George S.
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251075343.50
126 rdf:type schema:Person
127 sg:person.01271226125.41 schema:affiliation grid-institutes:grid.5216.0
128 schema:familyName Kollias
129 schema:givenName Anastasios
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271226125.41
131 rdf:type schema:Person
132 grid-institutes:None schema:alternateName Department of Cardiology, Venizeleio General Hospital, Heraklion, Crete, Greece
133 schema:name Department of Cardiology, Venizeleio General Hospital, Heraklion, Crete, Greece
134 rdf:type schema:Organization
135 grid-institutes:grid.411299.6 schema:alternateName Department of Internal Medicine, Larissa General Hospital, Larissa, Greece
136 schema:name Department of Internal Medicine, Larissa General Hospital, Larissa, Greece
137 rdf:type schema:Organization
138 grid-institutes:grid.5216.0 schema:alternateName Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
139 schema:name Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
140 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...